(1) Except as otherwise provided in ORS § 442.819 to 442.851, the Oregon Patient Safety Commission Board of Directors, or officials of the Oregon Patient Safety Commission acting under the authority of the board, shall exercise all the powers of the commission and shall govern the commission. The board shall adopt rules necessary for the implementation of the Oregon Patient Safety Reporting Program, including but not limited to:

(a) Developing a list of objective and definable adverse events to be reported by participants. In developing this list, the board shall consider similar lists developed in other states and nationally. The board may change the list from time to time.

(b) Developing a budget.

(c) Establishing a process to seek grants and other funding from federal and other sources.

(d) Establishing a method to determine participant fees, if necessary.

(e) Establishing auditing and oversight procedures, including a process to:

(A) Evaluate the effectiveness of the patient safety reporting program in advancing the mission of the commission described in ORS § 442.820 (2);

(B) Update, as needed, the list of adverse events developed under paragraph (a) of this subsection; and

(C) Obtain certification by the Public Health Officer that the commission is administering the patient safety reporting program consistent with the mission described in ORS § 442.820 (2) and the requirements of this section.

(2) The board may not use or disclose patient safety data reported, collected or developed pursuant to ORS § 442.819 to 442.851 for purposes of any enforcement or regulatory action in relation to a participant.

(3) The board shall maintain the confidentiality of all patient safety data that identifies or could be reasonably used to identify a participant or an individual who is receiving or has received health care from the participant. [2003 c.686 § 9; 2011 c.30 § 3; 2023 c.89 § 4]

See note under 442.819.